In an impressive turn of events, the U.S. Food and Drug Administration (FDA) has lifted the partial hold on BioNTech and MediLink Therapeutics' clinical trial for their groundbreaking Antibody-Drug Conjugate (ADC) candidate BNT326/YL202. Originally put on hold due to serious safety concerns,
VGXI Inc., a prominent Contract Development and Manufacturing Organization (CDMO) specializing in nucleic acid biopharmaceuticals, is making significant strides in the biopharmaceutical industry. Their recent inclusion in the Biopharmaceutical Manufacturing Preparedness (BioMAP) Consortium
The biopharmaceutical industry, or biopharma, stands at the forefront of medicine and biotechnology, bringing revolutionary advancements to patient care and medical treatments. Biopharma focuses on developing drugs from biological sources, offering a wide range of therapies that are changing lives.
Maccabi Health Services has taken a significant step toward safeguarding its medical and Internet of Things (IoT) devices from ransomware attacks by partnering with Cynerio, a startup specializing in healthcare cybersecurity. Being the second-largest health maintenance organization in Israel, which
Periodontitis remains one of the most common chronic inflammatory diseases affecting millions globally, characterized by an imbalance in the oral microbiome and prompted by pathogenic bacteria. Due to this imbalance, the body's immune response becomes inefficient, resulting in harm to
Human lips, being complex structures formed of mucosa, skin, and innervated skeletal muscles, are essential for various daily activities such as eating, drinking, talking, and social interactions. This makes their reconstruction, especially after traumatic injuries or cancer surgeries, a
Jim Wilson, a seminal figure in the field of gene therapy, is departing the University of Pennsylvania (UPenn) after an illustrious career spanning decades. His decision to step down marks a significant juncture for both the institution and the broader gene therapy landscape. Over the years, Wilson
The article delves into the escalating scrutiny by US lawmakers on Chinese biotech and medtech companies, which they allege pose significant national security risks. These legislative actions are part of a broader strategy to curb Chinese influence and secure US technology and intellectual
AbbVie's financial performance and strategic initiatives in 2022 demonstrate a concerted effort to drive growth and enhance its presence in the pharmaceutical and biopharmaceutical sectors. With revenues exceeding $58 billion, the year reflected significant advancements fueled by new product
The biopharma industry is abuzz with rumors of a potential takeover of CAR-T specialist Legend Biotech, a company renowned for its collaboration with Johnson & Johnson (J&J) on the BCMA CAR-T therapy Carvykti. An unnamed source cited by StreetInsider has revealed that Legend recently
